StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
NASDAQ:CALA opened at $0.05 on Friday. The stock has a 50 day moving average of $0.02 and a two-hundred day moving average of $0.02. Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.13.
Calithera Biosciences Company Profile
Read More
- Five stocks we like better than Calithera Biosciences
- How to Invest in the Best Canadian Stocks
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- Industrial Products Stocks Investing
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- Roth IRA Calculator: Calculate Your Potential Returns
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
